Descovy 200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FR0CJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,990
Award facts
- Contract value 100% obligated
- $16,989.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency has awarded a delivery order valued at $16,989.91 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets in quantities of 30, with an ultimate completion date of December 12, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being fulfilled from the vendor's location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to meet diverse medical supply needs through open competition, delivering everything from specialty medications and brand-name drugs to vaccines and medical devices across multiple therapeutic domains. This specific delivery order for DESCOVY, an antiretroviral medication, represents the company's continued role in supporting Defense Health Agency pharmaceutical requirements through the flexible and comprehensive Pharmaceutical Prime Vendor Global Program framework.
Quick answers
Who was awarded contract SPE2DR26FR0CJ?
SPE2DR26FR0CJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 11, 2025.
How much is contract SPE2DR26FR0CJ worth?
The government has obligated $16,990 on SPE2DR26FR0CJ.
Is contract SPE2DR26FR0CJ an order under another contract?
Yes. SPE2DR26FR0CJ is a delivery order under SPE2DR25D3006, an indefinite delivery contract.
Was contract SPE2DR26FR0CJ competed?
The extent of competition for SPE2DR26FR0CJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award